INVEX Therapeutics Ltd (IXC) — Defensive Interval Ratio
INVEX Therapeutics Ltd (IXC) has a Defensive Interval Ratio of 265 days as of December 2025. Defensive assets of AU$128.00K (cash AU$-, short-term investments AU$-, receivables AU$128.00K) cover 265 days of daily cash needs of AU$483.53/day. See INVEX Therapeutics Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
INVEX Therapeutics Ltd Defensive Interval Ratio (2019–2025)
This chart shows how INVEX Therapeutics Ltd's Defensive Interval Ratio has evolved across 7 annual periods from 2019 to 2025. As of December 2025, the ratio stands at 265 days, meaning defensive assets of AU$128.00K can fund 265 days of operations without new revenue. See IXC equity to assets ratio to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for INVEX Therapeutics Ltd (2019–2025)
The table below presents the year-by-year Defensive Interval Ratio for INVEX Therapeutics Ltd from 2019 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see INVEX Therapeutics Ltd stock valuation.
| Year | DIR (days) | Defensive Assets (AUD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 154 days | AU$92.79K | AU$604.37/day | AU$- | AU$- | ▲ +73 days |
| 2024 | 80 days | AU$94.98K | AU$1.18K/day | AU$- | AU$- | ▲ +3 days |
| 2023 | 77 days | AU$333.56K | AU$4.31K/day | AU$- | AU$- | ▲ +24 days |
| 2022 | 53 days | AU$145.72K | AU$2.75K/day | AU$- | AU$- | ▲ +41 days |
| 2021 | 12 days | AU$21.20K | AU$1.80K/day | AU$- | AU$- | ▼ -9 days |
| 2020 | 21 days | AU$116.88K | AU$5.52K/day | AU$- | AU$- | ▼ -12 days |
| 2019 | 33 days | AU$85.62K | AU$2.56K/day | AU$- | AU$- | — |